CP and cholestasis: These patients were more frequently female (46% vs. 27%; p = 0.001), less frequently associated with HIV as risk factor for PSVD diagnosis (2% vs. 16%; p = 0.018), yielded higher ceruloplasmin levels (30 ± 8 vs. 26 ± 7 mg/dL; p = 0.014) as well as higher cholestasis parameters (Table S1).